Tag Archives: Cross Creek Capital

Rapid Human DNA Identification System Producer IntegenX Raises $40 Million Financing to Speed Commercialization

IntegenX Inc. has secured $40 Million in Series C funding to accelerate development of the company’s product pipeline and the commercialization of its RapidHIT 200 Human Identification System into domestic and international markets. Industry observers expect this product to be disruptive and that it will create a new market for rapid analysis of human DNA […]

Continue Reading